This HTML5 document contains 104 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://dx.doi.org/10.1111/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37248327
rdf:type
wikibase:Item
schema:description
vetenskaplig artikel مقالة علمية نشرت في 19 مارس 2009 научни чланак videnskabelig artikel vědecký článek wissenschaftlicher Artikel bilimsel makale wetenschappelijk artikel scientific article published on 19 March 2009 article científic article scientifique наукова стаття, опублікована в березні 2009 artículu científicu espublizáu en 2009 articolo scientifico vedecký článok artigo científico
p:P577
wds:Q37248327-78FCB17A-1876-41EC-8122-4EB746C6C078
wdt:P577
2009-03-19T00:00:00Z
p:P2860
wds:Q37248327-0FBE2098-C993-431D-8520-3BA168541D6E wds:Q37248327-13F93C1F-1516-4637-9F7F-8BF2B7729E8E wds:Q37248327-2240170D-4B62-48ED-B633-057C57063F79 wds:Q37248327-35328539-ACFE-4AC2-B4BD-97BA21C4335D wds:Q37248327-5A09FA35-7CB0-45A9-8B0A-F035ED1158A7 wds:Q37248327-153879A3-EDBF-4170-BD06-B9FCD29187BA wds:Q37248327-21D4B3D3-815F-4E36-A654-2FCE41D11B8C wds:Q37248327-9FB64FC6-8C81-4AD8-B5DA-D76F18FCEC08 wds:Q37248327-ECC4F063-A350-4477-B741-06F068C0E80C wds:Q37248327-F8CB0D35-8074-4231-BCD6-E23A16583B37 wds:Q37248327-61C5B79D-ED43-4D0F-BD46-7D148CE5F4BC wds:Q37248327-8FE42887-993C-43FA-AEE2-684023050201 wds:Q37248327-943A7E21-F648-4AEA-A4AB-40357F25EACE wds:Q37248327-9C5D13D2-1918-42B5-98AF-F608E94F5CD2
wdt:P2860
wd:Q35848146 wd:Q46972453 wd:Q46549268 wd:Q33880642 wd:Q34815786 wd:Q36163971 wd:Q44620764 wd:Q33377526 wd:Q37075738 wd:Q34549410 wd:Q34585268 wd:Q34753416 wd:Q80776203 wd:Q43590431
p:P2093
wds:Q37248327-5E4C9250-77AB-413D-A589-678F7D6A53FD
wdt:P2093
Donna M Weber
rdfs:label
Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma. Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma. Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma.
skos:prefLabel
Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma. Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma. Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma.
schema:name
Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma. Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma. Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma.
p:P50
wds:Q37248327-19C8C985-1EF1-43E8-90A9-3A57125EF125 wds:Q37248327-2BBE43AD-A080-4C49-A45A-4C328B99D79E wds:Q37248327-7F347E6A-6EA6-455B-AB08-0094658FDB40 wds:Q37248327-8D461F91-EE1E-45BF-AFE3-8F2CE22320C6 wds:Q37248327-719142C9-5FAE-4108-813A-C70E3702846A wds:Q37248327-72A4CFC9-EA03-4DF8-89F3-EC7E5E380AA3 wds:Q37248327-75A4C6FF-9D3B-4091-BC25-AD9801E4AC85 wds:Q37248327-A57E8723-8282-44F6-8858-6B4350FA3A66 wds:Q37248327-CDEF7E97-7F89-4781-AEEB-1D51878FE394 wds:Q37248327-D023613B-0204-4936-9718-9D336276197C wds:Q37248327-D2CC1254-833E-4DA9-8D07-B42C31A8CD80
wdt:P50
wd:Q26338766 wd:Q85923649 wd:Q125230446 wd:Q110622925 wd:Q85789960 wd:Q96337703 wd:Q100529915 wd:Q85544110 wd:Q114442084 wd:Q114442083 wd:Q5930658
p:P1476
wds:Q37248327-1DA9A659-24F5-4C8D-92CF-BAE44D87BCE8
wdt:P1476
Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma
p:P304
wds:Q37248327-A3C4E9C7-B160-4A8E-A2E4-45F84CEA7916
wdt:P304
426-432
p:P31
wds:Q37248327-DC881A69-5F3D-4D0B-9A55-A35A5AD8F223
wdt:P31
wd:Q13442814
p:P921
wds:Q37248327-90870BD5-9702-41E8-B232-C7C5F84A1D94
wdt:P921
wd:Q422252
p:P698
wds:Q37248327-5F36797A-00B2-4016-BF9C-92FA4230E057
wdtn:P698
n12:19302559
wdt:P698
19302559
p:P1433
wds:Q37248327-5CBFBCAA-9ACA-4C53-96DE-E9B487D66685
wdt:P1433
wd:Q15765799
p:P433
wds:Q37248327-B1A832FE-49AC-48E0-B10E-A818C84F5D65
p:P478
wds:Q37248327-0BF06C20-D287-4393-AC26-9F64F8DE89F6
wdt:P433
6
wdt:P478
82
p:P356
wds:Q37248327-85900348-D822-44D6-9586-626604170678
wdtn:P356
n8:J.1600-0609.2009.01257.X
wdt:P356
10.1111/J.1600-0609.2009.01257.X
p:P5875
wds:Q37248327-A4C67BE5-244A-4CAB-95F2-DE63451CFDEA
wdt:P5875
24216239
p:P932
wds:Q37248327-84ECE64F-AEED-4B92-AC30-0FF30BEF99A1
wdt:P932
2704925